Skandinaviska Enskilda Banken (SEB) Portfolio holdings
AUM
$23B
1-Year Return
23.43%
This Quarter Return
-2.44%
1 Year Return
+23.43%
3 Year Return
+116.09%
5 Year Return
+203.29%
10 Year Return
–
AUM
$15.2B
AUM Growth
-$13.2M
(-0.09%)
Cap. Flow
+$557M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
1,018
New
74
Increased
253
Reduced
520
Closed
91
Top Buys
| 1 |
Microsoft
MSFT
|
$341M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$174M |
| 3 |
Amazon
AMZN
|
$96.4M |
| 4 |
Applied Materials
AMAT
|
$69.4M |
| 5 |
AbbVie
ABBV
|
$54.2M |
Top Sells
| 1 |
Apple
AAPL
|
$51M |
| 2 |
NVIDIA
NVDA
|
$38.6M |
| 3 |
Ryder
R
|
$31.7M |
| 4 |
Merck
MRK
|
$30.8M |
| 5 |
Johnson & Johnson
JNJ
|
$29.9M |
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Healthcare | 18.7% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
John Wiley & Sons Class A
WLY
$2.13B
| $717K | ﹤0.01% |
19,300
-4,000
| -17% | -$149K |
|
727
Southwest Airlines
LUV
$16.5B
| $715K | ﹤0.01% |
26,405
| – | – |
|
728
John B. Sanfilippo & Son
JBSS
$749M
| $692K | ﹤0.01% |
+7,000
| New | +$692K |
|
|
JBIO
729
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| $690K | ﹤0.01% |
1,453
| – | – |
|
|
QIWI
730
DELISTED
QIWI PLC
QIWI
| $690K | ﹤0.01% |
121,724
| – | – |
|
731
ANI Pharmaceuticals
ANIP
$2.07B
| $685K | ﹤0.01% |
+11,800
| New | +$685K |
|
|
AYX
732
DELISTED
Alteryx, Inc.
AYX
| $682K | ﹤0.01% |
18,086
+5,304
| +41% | +$200K |
|
733
Digi International
DGII
$1.29B
| $677K | ﹤0.01% |
25,100
-5,100
| -17% | -$138K |
|
|
GOGL
734
DELISTED
Golden Ocean Group
GOGL
| $672K | ﹤0.01% |
85,276
-49,904
| -37% | -$393K |
|
735
OSI Systems
OSIS
$3.93B
| $661K | ﹤0.01% |
5,600
-1,200
| -18% | -$142K |
|
736
Supernus Pharmaceuticals
SUPN
$2.58B
| $639K | ﹤0.01% |
23,200
-4,700
| -17% | -$129K |
|
737
HNI Corp
HNI
$2.14B
| $630K | ﹤0.01% |
18,200
-3,700
| -17% | -$128K |
|
738
Yelp
YELP
$2.02B
| $620K | ﹤0.01% |
14,900
-3,100
| -17% | -$129K |
|
739
A10 Networks
ATEN
$1.27B
| $610K | ﹤0.01% |
40,600
+37,100
| +1,060% | +$557K |
|
740
Cabot Corp
CBT
$4.31B
| $609K | ﹤0.01% |
8,800
+4,400
| +100% | +$305K |
|
741
PDF Solutions
PDFS
$788M
| $606K | ﹤0.01% |
18,700
+1,300
| +7% | +$42.1K |
|
742
Tencent Music
TME
$37.7B
| $602K | ﹤0.01% |
94,500
-633,400
| -87% | -$4.03M |
|
743
Grand Canyon Education
LOPE
$5.74B
| $584K | ﹤0.01% |
5,000
-1,000
| -17% | -$117K |
|
744
Progress Software
PRGS
$1.88B
| $584K | ﹤0.01% |
+11,100
| New | +$584K |
|
745
AtriCure
ATRC
$1.76B
| $578K | ﹤0.01% |
13,200
+200
| +2% | +$8.76K |
|
746
Intellia Therapeutics
NTLA
$1.29B
| $576K | ﹤0.01% |
18,223
| – | – |
|
747
Beazer Homes USA
BZH
$781M
| $573K | ﹤0.01% |
+23,000
| New | +$573K |
|
|
MRTX
748
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $572K | ﹤0.01% |
13,139
-35,214
| -73% | -$1.53M |
|
749
Ingredion
INGR
$8.24B
| $561K | ﹤0.01% |
5,700
-1,200
| -17% | -$118K |
|
750
ICF International
ICFI
$1.75B
| $556K | ﹤0.01% |
4,600
+2,200
| +92% | +$266K |
|